Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042362
Filing Date
2023-08-14
Accepted
2023-08-14 16:01:54
Documents
75
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-20230630.htm   iXBRL 10-Q 2964300
2 EX-10.1 scyx-ex10_1.htm EX-10.1 107428
3 EX-31.1 scyx-ex31_1.htm EX-31.1 21017
4 EX-31.2 scyx-ex31_2.htm EX-31.2 21064
5 EX-32.1 scyx-ex32_1.htm EX-32.1 14684
6 GRAPHIC img217347157_0.jpg GRAPHIC 3876
  Complete submission text file 0000950170-23-042362.txt   13388094

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20230630.xsd EX-101.SCH 64361
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scyx-20230630_cal.xml EX-101.CAL 63687
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20230630_pre.xml EX-101.PRE 415741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20230630_lab.xml EX-101.LAB 540700
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scyx-20230630_def.xml EX-101.DEF 247110
69 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20230630_htm.xml XML 3434447
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 231169594
SIC: 2834 Pharmaceutical Preparations